App for assessing the efficacy and safety of SAR442970 in moderate to severe HS.
Your app for the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
A research study app to provide information, obtain e-consent, and complete surveys...
The Essential3 study app will be used by participants through the study...
"This application has been created especially for the FABULINUS DRI17476study participants and...
With this app you can access study information such as FAQs. The...
"You will use this app to access 2 things throughout your participation...
You will use this app to consent and complete activities for the...
Created with AppPage.net
Similar Apps - visible in preview.